PAPER Jeong SY, Suh CH, Lim JS, Shim WH, Heo H, Choi Y, Kim HS, Kim SJ, Lee JH

Incidence of Amyloid-Related Imaging Abnormalities in Phase III Clinical Trials of Anti-Amyloid-β Immunotherapy: An Updated Meta-Analysis.

Neurology. 2025 Apr 22;104(8):e213483. Epub 2025 Mar 19 PubMed.

PAPER Wimo A, Handels R, Blennow K, Kirsebom KB, Selnes P, Bon J, Emersic A, Gonzalez-Ortiz F, Gregoric Kramberger M, Sköldunger A, Speh A, Timón-Reina S, Vromen E, Jelle Visser P, Winblad B, Fladby T

Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting.

J Alzheimers Dis. 2025 Mar 20;:13872877251323231. Epub 2025 Mar 20 PubMed.

PAPER Zhen Y, Gao L, Chen J, Gu L, Zhang Z

Altered face perception in amnestic mild cognitive impairment: Evidence from representational similarity analysis of event-related potential.

J Alzheimers Dis. 2025 Mar 20;:13872877251326294. Epub 2025 Mar 20 PubMed.

PAPER Qiu SD, Zhang DD, Ma LY, Li QY, Wang LY, Wang YD, Wang YC, Xiong SY, Tan L

Associations of metabolic syndrome with risks of dementia and cognitive impairment: A systematic review and meta-analysis.

J Alzheimers Dis. 2025 Mar 20;:13872877251326553. Epub 2025 Mar 20 PubMed.

PAPER Phillips JM, Dumitrescu LC, Archer DB, Regelson AN, Mukherjee S, Lee ML, Choi SE, Scollard P, Trittschuh EH, Kukull WA, Biber S, Mez J, Mahoney ER, Clifton M, Libby JB, Walters S, Bush WS, Engelman CD, Lu Q, Fardo DW, Widaman KF, Buckley RF, Mormino EC, Sanders RE, Clark LR, Gifford KA, Vardarajan B, Cuccaro ML, Pericak-Vance MA, Farrer LA, Wang LS, Schellenberg GD, Haines JL, Jefferson AL, Johnson SC, Albert MS, Keene CD, Saykin AJ, Risacher SL, Larson EB, Sperling RA, Mayeux R, Goate AM, Renton AE, Marcora E, Fulton-Howard B, Patel T, Bennett DA, Schneider JA, Barnes LL, Cruchaga C, Hassenstab J, Belloy ME, Andrews SJ, Resnick SM, Bilgel M, An Y, Beason-Held LL, Walker KA, Duggan MR, Klinedinst BS, Crane PK, Hohman TJ

Novel modelling approaches to elucidate the genetic architecture of resilience to Alzheimer's disease.

Brain. 2025 Mar 20; Epub 2025 Mar 20 PubMed.

PAPER Azargoonjahromi A, Eivazi M, Nasiri H, Tarhriz V, Payandeh Z, Alzheimer’s Disease Neuroimaging Initiative

Elevated CSF GAP-43 in Mild Cognitive Impairment Linked to Cognitive Impairment Through Increased Amyloid-β Accumulation, with a Shift to Reduced Amyloid-β Accumulation in Alzheimer's Disease.

J Mol Neurosci. 2025 Mar 20;75(2):39. PubMed.

PAPER Safai A, Buckingham WR, Jonaitis EM, Langhough RE, Johnson SC, Powell WR, Kind AJ, Bendlin BB, Tiwari P

Association of neighborhood disadvantage with cognitive function and cortical disorganization in an unimpaired cohort: An exploratory study.

Alzheimers Dement. 2025 Mar;21(3):e70095. PubMed.

PAPER Karakose S, Luchetti M, Stephan Y, Sutin AR, Terracciano A

Marital status and risk of dementia over 18 years: Surprising findings from the National Alzheimer's Coordinating Center.

Alzheimers Dement. 2025 Mar;21(3):e70072. PubMed.

PAPER Elzinga SE, Guo K, Turfah A, Henn RE, Webber-Davis IF, Hayes JM, Pacut CM, Teener SJ, Carter AD, Rigan DM, Allouch AM, Jang DG, Parent R, Glass E, Murphy GG, Lentz SI, Chen KS, Zhao L, Hur J, Feldman EL

Metabolic stress and age drive inflammation and cognitive decline in mice and humans.

Alzheimers Dement. 2025 Mar;21(3):e70060. PubMed.

PAPER Hayes CA, Young CB, Abdelnour C, Reeves A, Odden MC, Nirschl J, Crane PK, Poston KL, Mormino EC, Younes K

The impact of arteriolosclerosis on cognitive impairment in decedents without severe dementia from the National Alzheimer's Coordinating Center.

Alzheimers Dement. 2025 Mar;21(3):e70059. PubMed.

PAPER Abi-Ghanem C, Kelly RD, Groom EA, Valerian CG, Paul AS, Thrasher CA, Salinero AE, Batchelder MR, Lafrican JJ, Wang M, Smith RM, Temple S, Zuloaga DG, Zuloaga KL

Interactions between menopause and high-fat diet on cognition and pathology in a mouse model of Alzheimer's disease.

Alzheimers Dement. 2025 Mar;21(3):e70026. PubMed.

PAPER Sorial ME, Abdelghany RM, El Sayed NS

Modulation of the cognitive impairment associated with Alzheimer's disease by valproic acid: possible drug repurposing.

Inflammopharmacology. 2025 Mar 19; Epub 2025 Mar 19 PubMed.

PAPER Van Alstyne M, Pratt J, Parker R

Diverse influences on tau aggregation and implications for disease progression.

Genes Dev. 2025 Mar 20; Epub 2025 Mar 20 PubMed.

PAPER Bao H, Zheng S, Shen Y

Sexual dimorphism in cerebrovascular dysfunction: The pivotal role of endothelial CD2AP in Alzheimer's disease.

Neuron. 2025 Mar 19;113(6):797-800. PubMed.

PAPER Ayaz G, Sordu P, Küçüksezer UC, Hanağası H, Alaylıoğlu M, Gürvit H, Gezen-Ak D, Bilgiç B, Dursun E, Ulutin T

Association of glycoprotein 1b and miR-26a-5p levels with platelet function in Alzheimer's disease.

J Alzheimers Dis. 2025 Mar 20;:13872877251326204. Epub 2025 Mar 20 PubMed.